Yahoo Web Search

Search results

1. www.baxter.com › sites › gFOR IMMEDIATE RELEASE - Baxter

   www.baxter.com › sites › g

   On an adjusted basis, 2021 net income attributable to Baxter totaled $1.8 billion, or $3.61 per diluted share, an increase of 17% compared to the prior-year period. Adjusted results for full-year 2021 include a contribution to earnings of $0.08 per diluted share from Hillrom.

2. www.baxter.com › baxter-newsroom › baxter-reportsBaxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com › baxter-newsroom › baxter-reports

   • Cached

   Feb 9, 2023 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023.

3. last10k.com › sec-filings › baxBaxter International Inc (BAX) 10-K Annual Report February 2022

   last10k.com › sec-filings › bax

   Feb 23, 2022 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full year and first quarter 2022.

   • Author: Baxter International Inc

4. investor.baxter.com › investors › events-and-newsBaxter Reports Fourth-Quarter and Full-Year 2022 Results

   investor.baxter.com › investors › events-and-news

   • Cached

   Feb 9, 2023 · The accompanying schedules include additional details on sales performance by product categories and segments. For full-year 2022, net income (loss) attributable to Baxter totaled ($2.4 billion), or ($4.83) per diluted share on a U.S. GAAP basis.

5. s22.q4cdn.com › 911189824 › filesBAXTER — PAGE 11 BAXTER INTERNATIONAL INC. Consolidated ...

   s22.q4cdn.com › 911189824 › files

   The company’s results in 2022 and 2021 included intangible asset amortization expense of $753 million ($580 million, or $1.14 per diluted share, on an after-tax basis) and $298 million ($234 million, or $0.46 per diluted share, on an after-tax basis), respectively.

6. www.reuters.com › markets › companiesBAX.N - | Stock Price & Latest News | Reuters

   www.reuters.com › markets › companies

   Oct 10, 2024 · Get Baxter International Inc (BAX.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

7. People also ask

   How much did Baxter make in 2022?

   • The accompanying schedules include additional details on sales performance by product categories and segments. For full-year 2022, net income (loss) attributable to Baxter totaled ($2.4 billion), or ($4.83) per diluted share on a U.S. GAAP basis.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

   What was Baxter's net income in the fourth quarter?

   • For the fourth quarter, net income attributable to Baxter was $181 million, or $0.36 per diluted share, on a U.S. GAAP (Generally Accepted Accounting Principles) basis. These results include special items totaling $263 million after-tax, which were primarily related to intangible amortization, and goodwill and intangible asset impairments.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

   What is Baxter's financial outlook for 2023?

   • 2023 Financial Outlook For full-year 2023: Baxter expects sales growth of 1% to 2% on a reported basis and flat to 1% on a constant currency basis. The company expects U.S. GAAP earnings of $1.43 to $1.63 per diluted share and adjusted earnings, before special items, of $2.75 to $2.95 per diluted share.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

   How much cash does Baxter generate a year?

   • For the full year, Baxter generated $1.2 billion in operating cash flow from continuing operations and $532 million in free cash flow (operating cash flow from continuing operations less capital expenditures of $679 million).

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

   What does Baxter expect in 2023?

   • For full-year 2023: Baxter expects sales growth of 1% to 2% on a reported basis and flat to 1% on a constant currency basis. The company expects U.S. GAAP earnings of $1.43 to $1.63 per diluted share and adjusted earnings, before special items, of $2.75 to $2.95 per diluted share.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   investor.baxter.com/investors/events-and-news/news/press-release-details/2023/Baxter-Reports-Fourth-Quarter-and-Full-Year-2022-Results/default.aspx

   See all results for this question

   Is Baxter International a MedTech leader?

   • DEERFIELD, Ill. - 2023-02-09 Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

8. www.baxter.com › sites › gBAXTER — PAGE 11 BAXTER INTERNATIONAL INC. Consolidated ...

   www.baxter.com › sites › g

   10 The company's results in 2021 included an income tax benefit of $18 million, or $0.04 per diluted share related to a change in U.S. foreign tax credit regulations. For more information on the company's use of non-GAAP financial measures, please see the Non-GAAP Financial Measures section of this press release.